Progressive Supranuclear Palsy (PSP) Conference
Home/ Scientific Sessions / Progressive Supranuclear Palsy (PSP) Conference
Progressive Supranuclear Palsy (PSP)
Progressive Supranuclear Palsy (PSP) is an uncommon neurologic disease that affects movement, balance, speech, and eye movement. PSP is caused by damage to brain cells, specifically areas that control walking, coordination, and eye movement. People with PSP often have trouble balancing and tend to fall backwards. Stiffness, slurred speech, trouble swallowing, and trouble moving the eyes—specifically, up or down—are also seen in people with PSP. PSP symptoms may be mistaken for Parkinson’s disease, but it is more rapid in development and unresponsive to Parkinson’s drugs. PSP etiology is unknown, although PSP involves the accumulation of a protein called tau in the brain. No treatment exists, but its symptoms are managed with physical therapy, speech therapy, and care. PSP usually begins after the age of 60 and gradually deteriorates over time. Prompt treatment and management will make patients more comfortable and safer.
Related Sessions
1.Alzheimers and Parkinsons Diseases
2.Neuroimmunology and Neurological Infections
3 – Cognitive Neuroscience and Psychology
4 – Neuroinformatics and Computational Neuroscience
5 – Neurological Disorders
6 – Neurobiology
7 – Molecular Neuroscience
8 – Pediatric Neurology
9 – Clinical Neurology
10 – Translational Neurology
11 – Neurogenetics
12 – Neurodegenerative Diseases
13 – Neuropsychiatry
14 – Neuroscience Research
15 – Neuropharmacology and Novel Drug Development
16 – Neurological Interventions and Surgery
17 – Artificial Intelligence in Neurology and Neurosurgery
18 – Neuro-ophthalmology and Auditory Neurology
19 – Aging and Neurology
20 – Brain Tumors and Neuro-Oncology
21 – Stroke Diagnosis and Management
22 – Epilepsy and Seizure Disorders
23 – Psychiatric and Behavioral Disorders
24 – Neurovascular Disorders
25 – Neurology and Systemic Disorders
26 – Neurodevelopmental Disorders
27 – Cognitive and Memory Disorders
28 – Neuroinflammation and Brain Disorders
29 – Neurological Rehabilitation
31 – Trauma and Neurocritical Care
33 – Cellular and Systems Neuroscience
35 – Advances in Neuroimaging Techniques
37 – Rare and Complex Brain Disorders
30 – Global Challenges and Public Health
32 – Neurotoxicology
34 – Behavioral Neuroscience and Social Neuroscience
36 – Addiction and Mental Health
Scientific Program
Keynote Speaker - Dr. Zhenhuan LIU (Oral Presentation - In-Person)
Nanhai Maternity and Children Hospital Affiliated to Guangzhou University of Chinese Medicine, China
Keynote Speaker - Dr. Magda Tsolaki - Oral Presentation (Virtual)
Emeritus Professor of Neurology, Aristotle Univesrsity of Thessaloniki, Makedonia, Greece, Chair of the Greek Federation of Alzheimer’s Disease
Keynote Speaker - Dr. Tatsuro Mutoh, MD, PhD, FAAN - Oral Presentation (In-Person)
Department of Neurology, Fujita Health University Hospital, Toyoake, Aichi, Japan
Scientific Program
Keynote Speaker - Dr. Zhenhuan LIU (Oral Presentation - In-Person)
Nanhai Maternity and Children Hospital Affiliated to Guangzhou University of Chinese Medicine, China
Keynote Speaker - Dr. Magda Tsolaki - Oral Presentation (Virtual)
Emeritus Professor of Neurology, Aristotle Univesrsity of Thessaloniki, Makedonia, Greece, Chair of the Greek Federation of Alzheimer’s Disease
Keynote Speaker - Dr. Tatsuro Mutoh, MD, PhD, FAAN - Oral Presentation (In-Person)
Department of Neurology, Fujita Health University Hospital, Toyoake, Aichi, Japan
Committee Members
Kenneth B Storey
Carleton University, Canada
Kindy Mark
University of South Florida, United
Thomas J Webster
Interstellar Therapeutics, United States
Tags